Speakrs

Professor Carlos Gonçalo das Neves, a Portuguese and Norwegian citizen, graduated in Veterinary Medicine, from the Technical University of Lisbon in 2004, and obtained his PhD in veterinary science in 2009 from the Norwegian School of Veterinary Sciences. He holds also a Postgraduate Certificate in Public Health from the London School of Hygiene and Tropical Medicine, and a Certificate in Public Policy from the London School of Economics. He is the Chief Scientist of the European Food Safety Authority, having served previously between 2019 and 2022 as the Director of Research and Internationalization of the Norwegian Veterinary Institute (NVI), and between 2014 and 2017 as head of virology and head of food safety and emerging threats at the same institution. He holds a joint position as Full Professor at the Faculty of Medical Sciences at the University of Tromsø. Prof. das Neves has worked in the field of wildlife diseases, and has experience on topics related to ONE HEALTH, emerging threats, wildlife health and food safety and systems. He has a strong background in science to policy translation, advocacy and societal awareness. In 2013 he obtained the diploma of specialist of the European College of Zoological Medicine, and is currently the chair of the Wildlife Population Health Speciality. Between 2014-2018 we served also as an expert in animal welfare and health for the Norwegian Scientific Committee for Food and the Environment. He is a Commissioner of the Lancet ONE HEALTH Commission, and a member of the Global 1 Health Network and of the One Sustainable Health Forum, as well as a lead author on the ongoing IPBES Nexus assessment on the interlinkages among biodiversity, water, food and health. He is a Member of the IUCN Wildlife Health Specialist Group, and has served between 2019 and 2021 as the President of the Wildlife Disease Association. He has also served as Honorary Consul of Portugal in Norway between 2010 and 2017.   read more...   read less

Dr James Chan graduated with a Bachelor of Pharmacy degree and obtained his doctoral degree in Pharmaceutical Science from the National University of Singapore. Subsequently he joined A*STAR in 2018 and established an independent research group in 2020 in both the Singapore Institute of Food and Biotechnology Innovation (SIFBI), and the A*STAR Skin Research Labs (ASRL). He is currently a Junior Principal Investigator with extensive expertise in physiologically-based pharmacokinetic models. In particular, his team develops in vitro and in silico tools to investigate transporter-mediated pharmacokinetics. His current research interests include the modelling of long half-life environmental PFAS contaminants, prediction of the biokinetics for pharmaceutical, nutritional and consumer care compounds, and modelling sensitive populations such as pregnant mothers and maternal-fetal transfer.   read more...   read less

Dr. Djork-Arné Clevert has a background in computer science and received his doctorate on machine learning for computational biology. In 2022 he accepted a global role as VP, Head of Machine Learning Research within Pfizer Research. Prior to that, he was seven years in pharmaceutical research at Bayer and became Director, Head of Machine Learning Research in 2019. He was a senior scientist in the prestigious Hochreiter Lab at the Institute of Bioinformatics at Johannes Kepler University from 2007 to 2015. He has been Co-PI in several large projects with pharma industry, in particular, transcriptome analysis and statistical genetics with Johnson and Johnson and Merck Serono Geneva, respectively. His research has mainly been concerned with microarray data in earlier years. Later he shifted this research focus to the prediction of biological effects of compounds with methods, such as, deep neural networks. A highlight of his Marie Curie fellowship was the introduction of the Exponential Linear Units (ELUs), which has become a de-facto standard in the field of deep learning. Dr. Clevert is the author of over 60 research articles, scientific reviews, and book chapters with more than 10000 citations in total and released the Open Source software packages FARMS, cn.FARMS, RFN and Img2Mol.   read more...   read less

In 2022, Dr. Tammy Collins joined the Burroughs Wellcome Fund (BWF), a nonprofit philanthropic organization whose mission is to improve human health. At BWF, Dr. Collins serves as a Program Officer where she directs the Career Awards at the Scientific Interface (CASI) program and the Innovations in Regulatory Science Awards (IRSA). She serves on the US National Academies of Science, Engineering, and Medicine’s (NASEM) Forum on Drug Discovery, Development, & Translation as well as NASEM’s Forum on Regenerative Medicine. Prior to joining BWF, Dr. Collins served as Training Director at the National Institutes of Health | National Institute of Environmental Health Sciences (NIH | NIEHS) and was Chair-elect of the NIH-wide Training Directors’ Committee. At NIEHS, Dr. Collins made career outcomes of postdoctoral scholars transparent (see Nature Biotechnology publication). Dr. Collins received her bachelor’s in chemistry from Appalachian State University (ASU), and her Ph.D. in biochemistry from Duke University. After a brief postdoc at Duke, she joined NIEHS as a postdoc in 2009 where she developed her passion for helping foster scientific leaders.   read more...   read less

Dr. Cubadda is Senior Scientist and Team Leader at the Italian National Institute of Health with expertise in analytical sciences, exposure assessment and toxicology. He leads a group with a long track record in research on analytical determination and toxicology of nanomaterials as well as risk assessment of nanotechnology applications. Current interest is mainly in the area of NAMs in nanotoxicology, in which he coordinates international projects (NANOCELLUP, NAMS4NANO Lot 3). Expert in food safety risk assessment, in both the chemical and the nutritional domain, he has been member of several working groups of the European Food Safety Authority (EFSA) and is a current member of the Cross cutting Working Group on Nanotechnology. Author of >180 papers in international journals, he acted as chairman of national and international conferences and as lecturer for different Universities.   read more...   read less

Dr Jean Lou Dorne has been working in EFSA as a Senior Scientific Officer in Toxicology since 2006 and is currently working in the preparedness team of the Methodological and Scientific Support Unit. Previously, he spent 9 years at the University of Southampton between a PhD and 5 years of postdoctoral research UK on “human variability in kinetics and metabolism and refinement of uncertainty factors for chemical risk assessment”. His work focuses on NAMs in chemical risk assessment, toxicology, ecotoxicology including development of a)EFSA’s OpenFoodTox database and associated in silico tools, b) TKPlate 1.0 platform, c) harmonised methods for mixture risk assessment for humans, animals and the environment d)Training programmes in chemical risk assessment in the NAM area.   read more...   read less

Clinical physiologist and PhD in biology with 23 years of experience in drug discovery and drug development. Founder of Inoviem Scientific highly focused on personalised medicine using proprietary technologies and Artificial Intelligence platform to help pharma and biotech companies in develop of their compounds from early discovery to patient. Professor in experimental medicine at University hospital KSMA in Bishkek in connection to Germane higher education.

Dr. Hong Fang is a highly accomplished Senior Health Information Scientist at the US FDA, bringing over 20 years of experience in computational science, data science, chemoinformatics, toxicoinformatics, and bioinformatics to her role. At the FDA, Dr. Fang spearheads bioinformatics research and is responsible for the development of tools that support FDA's health informatics initiatives. A comprehensive list of the currently available software tools and informatics systems can be found on NCTR/FDA webpage: https://www.fda.gov/science-research/bioinformatics-tools. One noteworthy tool is FDALabel, which is hosted on the Amazon Cloud. FDALabel is a web-based application that facilitates full-text search of the FDA's drug labeling documents. It experienced a significant user access rate last year, with 100,000 visits recorded. In addition to her research and project management roles, Dr. Fang is a prolific writer. She has authored and co-authored a remarkable 164 manuscripts, accumulating an impressive 15,900 citations. Her Google Scholar H-Index is 59, highlighting the impact and influence of her scholarly contributions   read more...   read less

Dr. Anil Patri serves as the Director, Nanocore and Chairs FDA’s Nanotechnology Task Force to conduct and coordinate regulatory science research, provide reviewer training, and standards development. He serves on the Nanoscale Science, Engineering, and Technology Subcommittee (NSET) on behalf of FDA. He chairs the Nanotechnology Working Group of the Global Coalition for Regulatory Science Research (GCRSR) to address emerging challenges, consensus development and capacity building. Prior to joining FDA in 2014, Dr. Patri served as the Deputy Director, Nanotechnology Characterization Laboratory at the Frederick National Laboratories for Cancer Research to oversee the clinical translation of nanomedicines. A synthetic organic chemist by training, his graduate research was on dendritic nanomaterial, followed by exploring their potential for cancer targeting, imaging and drug delivery at the University of Michigan.   read more...   read less

With a PhD in Pharmacology and Toxicology from the University of California at Davis, I have authored or co-authored over 350 publications that have been cited over 18,000 times with topics including developmental neurotoxicology, pharmacokinetics, systems toxicology, emerging technologies and risk assessment. I have had the privilege to mentor a dozen PhD students and over 20 Postdoctoral Fellows, serve as director of the National Center for Toxicological Research/FDA for 16 years (recently retired) and as past president of the Teratology Society, the Academy of Toxicological Sciences and the Society of Toxicology.   read more...   read less